TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.

Daniel Umbricht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.